ENTITY
JD Health International

JD Health International (6618 HK)

365
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
Refresh
bearishPetroChina
15 Dec 2020 16:14

HSCEI Index Rebalance Preview: One Deletion For Sure, Could Be One More Change

Following JD Health's Fast Entry into the HSCEI, PetroChina is a high probability deletion in March. There is a low probability of Country Garden...

Logo
477 Views
Share
15 Dec 2020 09:58

JD Health (6618.HK) - Opportunities Coexist with Challenges

This article analyzed JD Health's current business model, the industry, its opportunities and challenges, the future development direction and...

Logo
348 Views
Share
15 Dec 2020 09:40

Blue Moon Group IPO Trading - Too Expensive for Our Liking but Retail Traders Seem to Like It

Blue Moon Group Holdings (BMG HK) (BMG) raised around US$1.4bn in its Hong Kong listing. The company is backed by Hillhouse who first invested in...

Logo
402 Views
Share
13 Dec 2020 09:59

ECM Weekly (13 December 2020) - Vesync, Sino-Ocean, Jacobio, Netjoy, Sea, Xpeng, NIO, and More!

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
10 Dec 2020 17:05

Pop Mart International IPO: Trading Debut

Pop Mart priced its IPO at HK$38.50 and opened 82% higher at HK$70.00 in the grey market. Our DCF sensitivity analysis shows that the IPO price...

Logo
467 Views
Share
x